Portrait of Dr. Amin Yehya

Dr. Amin Yehya

Director of Heart Failure Research & Medical Director of Durable Mechanical Circulatory Support

Associate Professor of Medicine, Cardiology

Advanced Heart Failure, Transplant Cardiology & Cardiovascular Education

Sentara Heart Hospital · EVMS at Old Dominion University | Norfolk, VA

Board-Certified in Internal Medicine, Cardiovascular Disease, and Advanced Heart Failure and Transplant Cardiology · FACC · FHFSA · ISHLT-F

About

About Dr. Yehya

Dr. Amin Yehya is a nationally and internationally recognized physician–scientist, educator, and academic leader whose career is distinguished by sustained excellence in advanced heart failure, mechanical circulatory support, cardiovascular research, and medical education. He serves as Director of Heart Failure Research and Medical Director of the Durable Mechanical Circulatory Support Program at Sentara Heart Hospital in Norfolk, Virginia.

He earned his Bachelor of Science in Chemistry, his medical degree, and a Master of Science in Biochemistry at the American University of Beirut, where he was inducted into the Alpha Omega Alpha Honor Medical Society. He completed Internal Medicine residency at Emory University, a Cardiovascular Disease fellowship at the Medical College of Georgia, and advanced training in Heart Failure and Transplant Cardiology at Stanford University.

Research and Clinical Focus

His research portfolio spans heart failure therapeutics, mechanical circulatory support, transplant cardiology, device therapy, and health equity. He has served as principal investigator on multiple international multicenter clinical trials, with work published in Circulation: Heart Failure, JACC: Heart Failure, and the Journal of Heart and Lung Transplantation, and many others.

Clinically, his interests encompass end-stage heart failure, durable and temporary mechanical circulatory support, heart transplantation, device therapy, and cardiogenic shock care delivery.

Education and Mentorship

Dr. Yehya is the inaugural Program Director of the Cardiovascular Disease Fellowship at Eastern Virginia Medical School at Old Dominion University, where he helped found and launch the institution's first cardiovascular fellowship. As Associate Professor of Medicine, he mentors medical students at the Macon & Joan Brock Virginia Health Sciences at ODU as well as residents and fellows in training.

In 2025 he was elected Chair of the HFSA Education Committee for a three-year term. He is a planning committee member and faculty for Turning the Tide on Diabetes, the Virginia Statewide Advanced Heart Failure Symposium, and the Sentara Mid-Atlantic Conference, and an invited speaker at ACC, HFSA, AHA, and ISHLT.

Recognition and Public Voice

He received the HFSA Top Principal Investigator Research Award, was named to the Avant-garde Health top 5% list of physicians publishing leading-edge cardiology research, and has been recognized as a Top Transplant Cardiologist in Virginia. His commentary has been featured in TIME Magazine, Physicians Weekly, Men's Journal, and other national outlets.

Appointments

Current roles & academic appointments

Director, Heart Failure Research

Sentara Health

Sept 2024 – present

Medical Director, Durable Mechanical Circulatory Support Program

Sentara Heart Hospital

Jul 2019 – present

Program Director, Cardiovascular Disease Fellowship

Eastern Virginia Medical School at ODU

Jul 2024 – present

Associate Professor of Medicine, Cardiology

Macon & Joan Brock Virginia Health Sciences at ODU

Sept 2022 – present

Clinical & research focus

Areas of expertise

Mechanical Circulatory Support

Medical direction of the durable LVAD program and temporary circulatory support strategies for end-stage heart failure.

Heart Failure & Transplant

Advanced heart failure management, transplant evaluation, and long-term post-transplant cardiology care.

Clinical Trials & Research

Principal investigator on international multicenter trials and investigator-initiated studies spanning device therapy and health equity.

Cardiovascular Education

Inaugural Program Director of the EVMS at ODU Cardiovascular Disease Fellowship; elected Chair of the HFSA Education Committee.

Education & training

Academic path

  1. Advanced Heart Failure & Transplant Fellowship

    2013 – 2014

    Stanford University

  2. Cardiovascular Disease Fellowship

    2010 – 2013

    Medical College of Georgia

  3. Internal Medicine Residency

    2007 – 2010

    Emory University School of Medicine

  4. Master of Science, Biochemistry

    2006 – 2007

    American University of Beirut

  5. Doctor of Medicine

    2002 – 2006

    American University of Beirut

  6. Bachelor of Science, Chemistry

    1999 – 2002

    American University of Beirut

Honors & awards

Recognition

Selected publications

Landmark research

Full list on Google Scholar →

Active research

Ongoing clinical trials

Dr. Yehya serves as Principal Investigator, Sub-Investigator, and Expert Panel member on national and international multicenter trials at Sentara Heart Hospital — spanning heart failure therapeutics, amyloidosis, mechanical circulatory support, and pulmonary hypertension.

HF-POLARIS

Expert Panel

Phase 3 randomized trial (Novo Nordisk) of NNC0487-0111 in patients with HFpEF/HFmrEF and obesity. Global & National Expert Panel.

Mar 2026 – present

CONFIRMATION-HF

Principal Investigator

Efficacy and safety of finerenone combined with an SGLT2 inhibitor in hospitalized heart failure patients.

May 2025 – present

RENEU-HF

Principal Investigator

Phase 2 randomized, double-blind, placebo-controlled study of JK07 in adults with chronic heart failure.

Jan 2025 – present

REDEFINE-HF

Principal Investigator

Efficacy and safety of finerenone on morbidity and mortality among hospitalized heart failure patients.

May 2024 – present

REVERSE-HF

Principal Investigator

Ultrafiltration vs IV diuretics in worsening heart failure — Aquadex System safety and effectiveness.

Sep 2023 – present

HERMES

Principal Investigator

Ziltivekimab vs placebo on morbidity and mortality in HFmrEF/HFpEF with systemic inflammation.

Jun 2023 – present

LVAD Weaning Registry

Principal Investigator

Registry for long-term outcomes after left ventricular assist device weaning.

May 2020 – present

TRITON-CM

Sub-Investigator

Phase 3 global study of nucresiran in transthyretin-mediated amyloidosis with cardiomyopathy.

Dec 2025 – present

ALIGN-AR

Sub-Investigator

JenaValve Trilogy System for high-surgical-risk patients with symptomatic, severe aortic regurgitation.

Sep 2025 – present

JENA-VAD Registry

Sub-Investigator

TAVR using JenaValve Trilogy for clinically significant aortic regurgitation in LVAD patients.

Sep 2025 – present

EASi-HF Preserved

Sub-Investigator

Phase III trial of vicadrostat + empagliflozin vs placebo + empagliflozin in HFpEF (LVEF ≥40%).

Jan 2025 – present

COR-PH

Sub-Investigator

Phase 1b study of COR-1389 on cardiopulmonary hemodynamics in pulmonary hypertension (PH-LHD).

Apr 2026 – present

EKO

Sub-Investigator

Deep-learning detection of pulmonary hypertension and reduced LVEF via a digital stethoscope + 3-lead ECG.

May 2026 – present

Aortix CRS Pilot

Sub-Investigator

Safety and performance of the Aortix System for intra-aortic mechanical circulatory support.

Nov 2021 – present

Author

My book

Heart Failure: What a Non-Heart Failure Specialist Needs to Know — book cover

Heart Failure

What a Non-Heart Failure Specialist Needs to Know

Editor: Amin Yehya, MD MS · Nova Science Publishers · 2018

A practical reference for non-heart-failure specialists, covering the evolving understanding and therapy of heart failure — from diagnosis and pharmacologic management through device therapy and mechanical circulatory support.

Buy on Amazon →

In the media

A trusted national voice

TIME Magazine

Why you feel anxious after drinking coffee

2025

Physicians Weekly

Rheumatoid Arthritis and Cardiovascular Risk

2026

WAVY News

Heart patients beating the odds with LVADs

2025

Men's Journal

Cardiologists warn against alcohol to protect heart health

2026

TCTMD

Rethinking the evidence for ICDs in HFrEF

2024

VeryWell Health

Foods to avoid when taking heart medications

2025

Videos & talks

Watch & learn

Connect

How to communicate with me

The best way to reach me depends on the nature of your message. Use the guide below to choose the right channel — it helps me respond faster and route your message to the right place.

Email — the best starting point

For research collaboration, speaking invitations, media inquiries, or general correspondence, email is the most reliable way to reach me.

Email me

Clinical referrals & appointments

For patient referrals, second opinions, or appointments, please contact the Sentara Advanced Heart Failure Center directly.

Sentara Advanced Heart Failure Center

600 Gresham Drive, Norfolk, VA 23507

Fellowship & mentorship

Medical students, residents, and prospective Cardiovascular Disease fellows are welcome to reach out via email or LinkedIn regarding mentorship and the EVMS at ODU fellowship program.

Speaking & media

For invited lectures, conference planning, or media commentary, email is preferred. You can also follow my public commentary on the channels below.